K Number
K212272
Device Name
Tempo Natural Tampon
Date Cleared
2021-09-17

(59 days)

Product Code
Regulation Number
884.5470
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Tempo Natural Tampon is intended for insertion into the vagina for the absorption of menstrual or other vaginal discharge.
Device Description
The Tempo Natural Tampon will be offered as a traditional unscented menstrual 100% organic cotton tampon consisting of an absorbent pledget, a withdrawal cord, and an applicator. The pledget is of the traditional cylindrical, bullet-like shape and the applicator has a standard rounded tip to ease insertion. Each tampon is individually wrapped and packaged in multi-unit containers. It will be offered in two absorbances: Regular and Super.
More Information

Not Found

No
The device description and performance studies focus on the physical properties and safety of a traditional tampon, with no mention of AI or ML.

No
The device is described as absorbing menstrual or other vaginal discharge, not treating or preventing a disease or condition.

No

This device is intended for absorption of menstrual or other vaginal discharge, not for diagnosing any condition.

No

The device description clearly states it is a physical tampon made of cotton with an applicator and withdrawal cord, which are hardware components. There is no mention of any software functionality.

Based on the provided information, the Tempo Natural Tampon is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for the absorption of menstrual or other vaginal discharge. This is a physical function within the body, not a diagnostic test performed on a sample outside the body.
  • Device Description: The description details a physical device for absorption, not a reagent, instrument, or system used to examine specimens from the human body to provide information for diagnosis, monitoring, or screening.
  • Lack of Diagnostic Elements: There is no mention of analyzing biological samples, detecting specific substances, or providing diagnostic information.
  • Performance Studies: The performance studies focus on physical characteristics, safety (biocompatibility, microbiology), and absorbency, which are relevant to a physical medical device, not an IVD.

IVDs are devices used to perform tests on samples such as blood, urine, or tissue to detect diseases, conditions, or infections. The Tempo Natural Tampon does not fit this description.

N/A

Intended Use / Indications for Use

The Tempo Natural Tampon is intended for insertion into the vagina for the absorption of menstrual or other vaginal discharge.

Product codes (comma separated list FDA assigned to the subject device)

HEB

Device Description

The Tempo Natural Tampon will be offered as a traditional unscented menstrual 100% organic cotton tampon consisting of an absorbent pledget, a withdrawal cord, and an applicator. The pledget is of the traditional cylindrical, bullet-like shape and the applicator has a standard rounded tip to ease insertion. Each tampon is individually wrapped and packaged in multi-unit containers. It will be offered in two absorbances: Regular and Super.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

vagina

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Performance testing was conducted in accordance with the 2005 FDA guidance document "Menstrual Tampons and Pads: Information for Premarket Notification Submissions (510(k)s) - Guidance for Industry and FDA Staff." The assessed characteristics include: Dimensions, Absorbency range, Chemical residues, Withdrawal cord strength, Fiber shedding, and Tampon integrity.

Biocompatibility studies were performed in accordance with the FDA guidance document "Use of International Standard ISO 10993-1, "Biological Evaluation of Medical Devices - Part 1: Evaluation and testing within a risk management process" issued in 2016 and ISO 10993 standards. Specific tests included: Cytotoxicity per ISO 10993-5:2009, Sensitization per ISO 10993-10:2010, Irritation per ISO 10993-10:2010, and Acute Systemic Toxicity per ISO 10993-11:2006. These tests were performed on the subject tampons and applicators, and the results satisfied the ISO standards requirements.

Microbiology testing was conducted per the 2005 FDA guidance document to demonstrate that the subject devices do not: Enhance the growth of Staphylococcus aureus, Increase the production of Toxic Shock Syndrome Toxin-1 (TSST-1), or Alter the growth of normal vaginal microflora.

The results of performance testing demonstrate that the Tempo Natural Tampon is as safe and effective as the predicate device and supports a determination of substantial equivalence.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K182817

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 884.5470 Unscented menstrual tampon.

(a)
Identification. An unscented menstrual tampon is a device that is a plug made of cellulosic or synthetic material that is inserted into the vagina and used to absorb menstrual or other vaginal discharge. This generic type of device does not include menstrual tampons treated with scent (i.e., fragrance materials) or those with added antimicrobial agents or other drugs.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the symbol of the Department of Health & Human Services on the left and the FDA acronym along with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a square and the full name written out next to it.

September 17, 2021

Dong-A Pharmaceutical Co., Ltd. % Joyce Kwon President Provision Consulting Group, Inc. 100 N. Barranca St. Suite 700 West Covina, CA 91791

Re: K212272

Trade/Device Name: Tempo Natural Tampon Regulation Number: 21 CFR§ 884.5470 Regulation Name: Unscented Menstrual Tampon Regulatory Class: II Product Code: HEB Dated: July 16, 2021 Received: July 20, 2021

Dear Joyce Kwon:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

1

You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Jason Roberts -S

Jason R. Roberts, Ph.D. Assistant Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K212272

Device Name Tempo Natural Tampon

Indications for Use (Describe)

The Tempo Natural Tampon is intended for insertion into the vagina for the absorption of menstrual or other vaginal discharge.

Type of Use (Select one or both, as applicable)
---------------------------------------------------

Prescription Use (Part 21 CFR 801 Subpart D)

X Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

K212272 Page 1 of 3

510(k) Summary - K212272

Submitter

Hyunjeong Jang Dong-A Pharmaceutical Co., Ltd. 64 Cheonho-daero, Dongdaemun-gu, Seoul, 02587 Republic of Korea

Official Correspondent

Joyce Kwon Provision Consulting Group, Inc. 100 N. Barranca St. Suite 700 West Covina, CA 91791

Date Prepared

Sept 15, 2021

Device Information

Trade Name: Tempo Natural Tampon Common Name: Unscented Menstrual Tampon Classification Name: Tampon, Menstrual, Unscented Product Code: HEB Regulation Number: 21 CFR 884.5470 Regulatory Class: Class II

Predicate Devices

Taebong CottonDay Tampon (K182817)

The predicate device has not been subject to any design-related recalls.

Indication for Use

The Tempo Natural Tampon is intended for insertion into the vagina for the absorption of menstrual or other vaginal discharge.

Device Description

The Tempo Natural Tampon will be offered as a traditional unscented menstrual 100% organic cotton tampon consisting of an absorbent pledget, a withdrawal cord, and an applicator. The pledget is of the traditional cylindrical, bullet-like shape and the applicator has a standard rounded tip to ease insertion. Each tampon is individually wrapped and packaged in multi-unit containers. It will be offered in two absorbances: Regular and Super.

4

Substantial Equivalent Comparison Chart
Subject DevicePredicate Device (K182817)
Product NameTempo Natural TamponTaebong CottonDay Tampon
Classification
Regulation884.5470884.5470
Product CodeHEBHEB
Indications for UseThe device is intended for
insertion into the vagina for the
absorption of menstrual or
other vaginal discharge.The device is intended for
insertion into the vagina for the
absorption of menstrual or
other vaginal discharge.
Sterile?NoNo
DesignTampon with cylindrical shape
and bullet-like tip. Applicator
with smooth, rounded tip.Tampon with cylindrical shape
and bullet-like tip. Applicator
with smooth, rounded tip.
Syngyna Absorbency
(gram)Regular 6.0 – 9.0Regular 6.0 – 9.0
Super 9.0 – 12.0Super 9.0 – 12.0
Pledget Length (mm)Regular 38Regular 38
Super 47Super 47
Pledget Diameter (mm)Regular 12Regular 12
Super 12Super 12
Applicator Inner Length
(mm)Regular 73 ± 5%Regular 73 ± 5%
Super 73 ± 5%Super 73 ± 5%
Applicator Outer Length
(mm)Regular 76.5 ± 5%Regular 76.5 ± 5%
Super 76.5 ± 5%Super 76.5 ± 5%
Applicator Inner
Diameter (mm)Regular 11.8 ± 5%Regular 11.8 ± 5%
Super 11.8 ± 5%Super 11.8 ± 5%
Applicator Outer
Diameter (mm)Regular 14.1 ± 5%Regular 14.1 ± 5%
Super 14.1 ± 5%Super 14.1 ± 5%
MaterialsPledget 100% Organic CottonPledget 100% Organic Cotton
Applicator PolyethyleneApplicator Polyethylene

Substantial Equivalent Comparison Chart

Basis for Substantial Equivalence

The subject device is identical to the predicate device with the same material composition and dimensional characteristics. The subject and predicate device have the same intended use.

5

Non-Clinical Test Data

Performance Testing

The following performance characteristics were assessed in accordance with the 2005 FDA guidance document "Menstrual Tampons and Pads: Information for Premarket Notification Submissions (510(k)s) - Guidance for Industry and FDA Staff."

  • Dimensions
  • Absorbency range ●
  • Chemical residues
  • Withdrawal cord strength ●
  • Fiber shedding ●
  • . Tampon integrity

Biocompatibility Testing

Biocompatibility studies were performed in accordance with the FDA guidance document "Use of International Standard ISO 10993-1, "Biological Evaluation of Medical Devices - Part 1: Evaluation and testing within a risk management process" issued in 2016 and ISO 10993 standards as follows:

  • Cytotoxicity per ISO 10993-5:2009 ●
  • Sensitization per ISO 10993-10:2010 ●
  • Irritation per ISO 10993-10:2010
  • Acute Systemic Toxicity per ISO 10993-11:2006 ●

These tests were performed on the subject tampons and applicators, and the results satisfied the ISO standards requirements.

Microbiology Testing

Per the 2005 FDA guidance document mentioned above, microbiology testing was conducted to demonstrate that the subject devices do not:

  • Enhance the growth of Staphylococcus aureus ●
  • Increase the production of Toxic Shock Syndrome Toxin-1 (TSST-1)
  • Alter the growth of normal vaginal microflora

Conclusions

The results of performance testing demonstrate that the Tempo Natural Tampon is as safe and effective as the predicate device and supports a determination of substantial equivalence.